Burning Rock Biotech (BNR) Equity Average (2022 - 2023)

Burning Rock Biotech has reported Equity Average over the past 2 years, most recently at $134.8 million for Q4 2023.

  • Quarterly results put Equity Average at $134.8 million for Q4 2023, down 40.29% from a year ago — trailing twelve months through Dec 2023 was $134.8 million (down 40.29% YoY), and the annual figure for FY2023 was $140.4 million, down 38.78%.
  • Equity Average for Q4 2023 was $134.8 million at Burning Rock Biotech, down from $225.7 million in the prior quarter.
  • Over the last five years, Equity Average for BNR hit a ceiling of $225.7 million in Q4 2022 and a floor of $134.8 million in Q4 2023.